Facility Expansion: A Pillar for Sustained Growth ELTP’s expanded facility is not merely designed to meet immediate demand for Generic Vyvanse. It is structured to support a broader pipeline of products, including upcoming launches like Generic Percocet and Generic Norco. This scalability ensures ELTP can efficiently manage growth and maintain market competitiveness in both the ADHD and pain management segments for years to come.